Treatment of Kratom Withdrawal and Addiction With Buprenorphine

被引：30

作者：

Khazaeli, Azin ^{[1
]}

Jerry, Jason M. ^{[2
]}

Vazirian, Mohsen ^{[1
,3
]}

机构：

[1] Cleveland Clin, Ctr Behav Hlth, Cleveland, OH 44106 USA

[2] FirstHlth Moore Reg Hosp, Pinehurst, NC USA

[3] Cleveland Clin, Lutheran Hosp, Alcohol & Drug Recovery Ctr, Cleveland, OH 44106 USA

来源：

JOURNAL OF ADDICTION MEDICINE | 2018年 / 12卷 / 06期

关键词：

buprenorphine; kratom; opioids;

D O I：

10.1097/ADM.0000000000000435

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

In this article, we describe a middle-aged woman with a history of addiction to opioid medications who eventually became dependent on kratom. Her kratom-related withdrawal symptoms responded to a trial of buprenorphine-naloxone. Subsequently, she was maintained on this medication.

引用

页码：493 / 495

页数：3

共 16 条

[1]

Alford DP, 2015, MANAGING ACUTE CHRON

[2]

Anwar M, 2016, MMWR-MORBID MORTAL W, V65, P748, DOI 10.15585/mmwr.mm6529a4

[3] Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth) [J].

Boyer, Edward W. ;

Babu, Kavita M. ;

Adkins, Jessica E. ;

McCurdy, Christopher R. ;

Halpern, John H. .

ADDICTION, 2008, 103 (06) :1048-1050

[4]

Casadonte PP, 2006, BUPRENORPHINE INDUCT

[5] Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries [J].

Cinosi, Eduardo ;

Martinotti, Giovanni ;

Simonato, Pierluigi ;

Singh, Darshan ;

Demetrovics, Zsolt ;

Roman-Urrestarazu, Andres ;

Bersani, Francesco Saverio ;

Vicknasingam, Balasingam ;

Piazzon, Giulia ;

Li, Jih-Heng ;

Yu, Wen-Jing ;

Kapitany-Foeveny, Mate ;

Farkas, Judit ;

Di Giannantonio, Massimo ;

Corazza, Ornella .

BIOMED RESEARCH INTERNATIONAL, 2015, 2015

[6] Kratom, an Emerging Drug of Abuse: A Case Report of Overdose and Management of Withdrawal [J].

Diep, Jack ;

Chin, David Tian ;

Gupta, Somdatta ;

Syed, Faraz ;

Xiong, Ming ;

Cheng, Jianguo .

A & A PRACTICE, 2018, 10 (08) :192-194

[7]

Drug Enforcement Administration, 2016, DEA ANN INT SCHED KR

[8]

Drug Enforcement Administration, 2016, Fed. Regist, V81, P70652

[9]

FDA, 2018, FDA INV MULT OUTBR S

[10]

Food and Drug Administration, 2002, BUPR DRUG LAB

← 1 2 →